Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like HIMA talks functional safety concepts at ARC Industry Forum February 22, 2018 CC-Link Partner Association and Renesas announce R-IN32M4-CL2 industrial Ethernet communication system-on-chip (SoC) March 21, 2018 Siemens introduces Sidrive IQ digital platform October 31, 2018
CC-Link Partner Association and Renesas announce R-IN32M4-CL2 industrial Ethernet communication system-on-chip (SoC) March 21, 2018